Allergan plc announced that Paul Bisaro will be retiring from its Board of Directors, as part of the company's ongoing board refreshment process. Following the retirement of Mr. Bisaro and the previously announced retirement of Fred G. Weiss and addition of Michael E. Greenberg, PhD, Allergan's Board of Directors will have 11 members of which 10 are independent.